BRIGHTGENE BIO-MEDICAL TECHNOLOGY C revenue breakdown overview

BRIGHTGENE BIO-MEDICAL TECHNOLOGY C revenue for the last year amounted to 1.18 B CNY, the most of which — 1.15 B CNY — came from its highest performing source at the moment, Product, the year earlier bringing 1.02 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought BRIGHTGENE BIO-MEDICAL TECHNOLOGY C 1.28 B CNY, and the year before that — 1.18 B CNY.